The 2003 Nicolas Andry award: Orthopaedic gene therapy

Clinical Orthopaedics and Related Research

Volumn 429, Issue , 2004, Pages 316-329

  Evans, Christopher H ^a   Ghivizzani, Steven C ^b   Robbins, Paul D ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; DNA; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; OSTEOGENIC PROTEIN 1; PARVOVIRUS VECTOR; RECOMBINANT DNA; RETROVIRUS VECTOR; RNA; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR;

BONE TUMOR; CARTILAGE; CLINICAL TRIAL; FRACTURE HEALING; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HERPES SIMPLEX VIRUS; HUMAN; INTERVERTEBRAL DISK HERNIA; KNEE MENISCUS RUPTURE; LIGAMENT INJURY; NONHUMAN; ORTHOPEDICS; OSTEOARTHRITIS; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REVIEW; RHEUMATOID ARTHRITIS; TENDON INJURY; TISSUE REPAIR; TRANSGENE; ANIMAL; AWARDS AND PRIZES; BONE DISEASE; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; FORECASTING; MALE; MUSCULOSKELETAL DISEASE; PROGNOSIS; RISK ASSESSMENT; STANDARD; TREATMENT OUTCOME; UNITED STATES;

ANIMALS; ARTHRITIS, RHEUMATOID; AWARDS AND PRIZES; BONE DISEASES; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FEMALE; FORECASTING; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MUSCULOSKELETAL DISEASES; ORTHOPEDICS; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 9644303031     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000148854.14399.ec     Document Type: Review

References (108)

1. Aposhian HV: The use of DNA for gene therapy-the need, experimental approach, and implications. J Hered 13:98-108, 1970.
2. Bakker AC, Joosten LA, Arntz OJ, et al: Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40:893-900, 1997.
3. Balk ML, Bray J, Day C, et al: Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Bone 21:7-15, 1997.
4. Baltzer AW, Lattermann C, Whalen JD, et al: A gene therapy approach to accelerating bone healing: Evaluation of gene expression in a New Zealand White rabbit model. Knee Surg Sports Traumatol Arthrosc 7:197-202, 1999.
5. Baltzer AW, Lattermann C, Whalen JD, et al: Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7:734-739, 2000.
6. Baltzer AW, Whalen JD, Wooley P, et al: Gene therapy for osteoporosis: Evaluation in a murine ovariectomy model. Gene Ther 8:1770-1776, 2001.
7. Bandara G, Mueller GM, Galea-Lauri J, et al: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764-10768, 1993.
8. Bandara G, Robbins PD, Georgescu HI, et al: Gene transfer to synoviocytes: Prospects for gene treatment of arthritis. DNA Cell Biol 11:227-231, 1992.
9. Beadle GW: Genes and the chemistry of the organism. Am Sci 34:31-53, 1946.
10. Bonadio J, Smiley E, Patil P, et al: Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 5:753-759, 1999.
11. Caplan AI, Bruder SP: Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264, 2001.
12. Chan JM, Villarreal G, Jin WW, et al: Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 6:727-736, 2002.
13. Check E: Second cancer case halts gene-therapy trials. Nature 421:305, 2003.
14. Einhorn TA: Clinical applications of recombinant human BMPs: Early experience and future development. J Bone Joint Surg 85A(Suppl 3):82-88, 2003.
15. Evans C, Goins WF, Schmidt MC, et al: Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis. Adv Drug Deliv Rev 27:41-57, 1997.
16. Evans C, Robbins PD: Prospects for treating arthritis by gene therapy. J Rheumatol 21:779-782, 1994.
17. Evans CH: Gene therapies for osteoarthritis. Curr Rheumatol Rep 6:31-40, 2004.
18. Evans CH: Orthopaedics: Gene therapy's dark horse. Gene Ther 11:343, 2004.
19. Evans CH, Bandara G, Mueller G, et al: Synovial cell transplants for gene transfer to joints. Transplant Proc 24:2966, 1992.
20. Evans CH, Ghivizzani SC, Herndon JH, et al: Gene therapy for the treatment of musculoskeletal diseases. J Am Acad Orthop Surg, In Press.
21. Evans CH, Ghivizzani SC, Herndon JH, et al: Clinical trials in the gene therapy of arthritis. Clin Orthop 379((Suppl)):S300-S307, 2000.
22. Evans CH, Ghivizzani SC, Kang R, et al: Gene therapy for rheumatic diseases. Arthritis Rheum 42:1-16, 1999.
23. Evans CH, Ghivizzani SC, Smith P, et al: Using gene therapy to protect and restore cartilage. Clin Orthop 379((Suppl)): S214-S219, 2000.
24. Evans CH, Gouze JN, Gouze E, et al: Osteoarthritis gene therapy. Gene Ther 11:379-389, 2004.
25. Evans CH, Palmer G, Pascher A, et al: Genetically Enhanced Tissue Engineering without Cell Culture or Manufactured Scaffolds. In Sandell LJ, Grodzinsky AJ (eds). Tissue Engineering in Musculoskeletal Clinical Practice. Rosemont IL, American Academy of Orthopaedic Surgeons 389-394, 2004.
26. Evans CH, Robbins PD: Gene therapy of arthritis. Intern Med 38:233-239, 1999.
27. Evans CH, Robbins PD: Genetically augmented tissue engineering of the musculoskeletal system. Clin Orthop 367(Suppl):S410-S418, 1999.
28. Evans CH, Robbins PD: Potential treatment of osteoarthritis by gene therapy. Rheum Dis Clin North Am 25:333-344, 1999.
29. Evans CH, Robbins PD: Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8:230-234, 1996.
30. Evans CH, Robbins PD: Possible orthopaedic applications of gene therapy. J Bone Joint Surg 77A:1103-1114, 1995.
31. Evans CH, Robbins PD: Progress toward the treatment of arthritis by gene therapy. Ann Med 27:543-546, 1995.
32. Evans CH, Robbins PD, Ghivizzani SC, et al: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7:1261-1280, 1996.
33. Evans CH, Scully SP: Editorial comment. Clin Orthop 379(Suppl):S2, 2000.
34. Evans CH, Whalen JD, Ghivizzani SC, et al: Gene therapy in autoimmune diseases. Ann Rheum Dis 57:125-127, 1998.
35. Fang J, Zhu YY, Smiley E, et al: Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 93:5753-5758, 1996.
36. Frisbie DD, Ghivizzani SC, Robbins PD, et al: Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 9:12-20, 2002.
37. Garrod AE: The incidence of alkaptonuria: A study in chemical individuality. Lancet 1616-1620, 1902.
38. Gerich TG, Kang R, Fu FH, et al: Gene transfer to the rabbit patella tendon: Potential for genetic enhancement of ligament and tendon healing. Gene Ther 3:1089-1093, 1996.
39. Ghivizzani SC, Lechman ER, Kang R, et al: Direct adenovirus-mediated gene transfer of interleukin I and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 95:4613-4618, 1998.
40. Ghivizzani SC, Oligino TJ, Glorioso JC, et al: Direct gene delivery strategies for the treatment of rheumatoid arthritis. Drug Discov Today 6:259-267, 2001.
41. Ghivizzani SC, Oligino TJ, Glorioso JC, et al: Gene therapy approaches for treating rheumatoid arthritis. Clin Orthop 379(Suppl):S288-S299, 2000.
42. Goater JJ, O'Keefe RJ, Rosier RN, et al: Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20:169-173, 2002.
43. Goto H, Shuler FD, Lamsam C, et al: Transfer of lacZ marker gene to the meniscus. J Bone Joint Surg 81A:918-925, 1999.
44. Goto H, Shuler FD, Niyibizi C, et al: Gene therapy for meniscal injury: Enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1)gene. Osteoarthritis Cartilage 8:266-271, 2000.
45. Gouze E, Ghivizzani SC, Robbins PD, et al: Gene therapy for rheumatoid arthritis. Curr Rheumatol Rep 3:79-85, 2001.
46. Gouze E, Pawliuk R, Gouze JN, et al: Lentiviral-mediated gene delivery to synovium: Potent intra-articular expression with amplification by inflammation. Mol Ther 7:460-466, 2003.
47. Gouze E, Pawliuk R, Pilapil C, et al: In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 5:397-404, 2002.
48. Herndon JH, Robbins PD, Evans CH: Arthritis: Is the cure in your genes? J Bone Joint Surg 81A:152-157, 1999.
49. Hildebrand KA, Deie M, Allen CR, et al: Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: The use of different viral vectors and the effects of injury. J Orthop Res 17:37-42, 1999.
50. Hildebrand KA, Frank CB, Hart DA: Gene intervention in ligament and tendon: Current status, challenges, future directions. Gene Ther 11:368-378, 2004.
51. Hotchkiss RD: Portents for a genetic engineering. J Hered 56: 197-202, 1965.
52. Hung GL, Galea-Lauri J, Mueller GM, et al: Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1:64-69, 1994.
53. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT: Osteolysis: Basic science. Clin Orthop 393:71-77, 2001.
54. Kang R, Ghivizzani SC, Herndon JH, et al: Gene therapy for arthritis: Principles and clinical practice. Biochem Soc Trans 25:533-537, 1997.
55. Kang R, Marui T, Ghivizzani SC, et al: Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study. Osteoarthritis Cartilage 5:139-143, 1997.
56. Kim JM, Ho SH, Park EJ, et al: Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis. Arthritis Rheum 46:793-801, 2002.
57. Kim SH, Evans CH, Kim S, et al: Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Res 2:293-302, 2000.
58. Kim SH, Kim S, Evans CH, et al: Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol 166:3499-3505, 2001.
59. Kim SH, Kim S, Robbins PD: Retroviral vectors. Adv Virus Res 55:545-563, 2000.
60. Kim SH, Lechman ER, Kim S, et al: Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. Mol Ther 6:591-600, 2002.
61. Kootstra NA Verma IM: Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43:413-439, 2003.
62. Lai CM, Lai YK, Rakoczy PE: Adenovirus and adeno-associated virus vectors. DNA Cell Biol 21:895-913, 2002.
63. Lechman ER, Jaffurs D, Ghivizzani SC, et al: Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 163:2202-2208, 1999.
64. Li S, Ma Z: Nonviral gene therapy. Curr Gene Ther 1:201-226, 2001.
65. Lieberman JR, Ghivizzani SC, Evans CH: Gene transfer approaches to the healing of bone and cartilage. Mol Ther 6:141-147, 2002.
66. Makarov SS, Olsen JC, Johnston WN, et al: Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93:402-406, 1996.
67. Mi Z, Ghivizzani SC, Lechman E, et al: Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther 5:R132-R139, 2003.
68. Mi Z, Ghivizzani SC, Lechman ER, et al: Adenovirus-mediated gene transfer of insulin-like growth factor I stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum 43:2563-2570, 2000.
69. Murray MM, Bennett R, Zhang X, et al: Cell outgrowth from the human ACL in vitro: Regional variation and response to TGFbeta1. J Orthop Res 20:875-880, 2002.
70. Murray MM, Martin SD, Spector M: Migration of cells from human anterior cruciate ligament explants into collagen-glycosaminoglycan scaffolds. J Orthop Res 18:557-564, 2000.
71. Murray MM, Spector M: The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro. Biomaterials 22:2393-2402, 2001.
72. Musgrave DS, Bosch P, Ghivizzani S, et al: Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24:541-547, 1999.
73. Neumann E, Judex M, Kullmann F, et al: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 9:1508-1519, 2002.
74. Nishida K, Gilbertson LG, Robbins PD, et al: Potential applications of gene therapy to the treatment of intervertebral disc disorders. Clin Orthop 379(Suppl):S234-S241, 2000.
75. Nishida K, Kang JD, Gilbertson LG, et al: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 24:2419-2425, 1999.
76. Nita I, Ghivizzani SC, Galea-Lauri J, et al: Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39:820-828, 1996.
77. Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P: Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alphal(I) and alpha2(I) heterotrimers in vitro and in vivo. J Cell Biochem 83:84-91, 2001.
78. Niyibizi C, Smith P, Mi Z, Robbins P, Evans C: Potential of gene therapy for treating osteogenesis imperfecta. Clin Orthop 379(Suppl):S126-S133, 2000.
79. Niyibizi C, Wang S, Mi Z, et al: The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: Implications for skeletal gene therapy via stem cells. Mol Ther 9:955-963, 2004.
80. Okubo Y, Bessho K, Fujimura K, et al: In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector. J Bone Joint Surg 83A(Suppl 1):S99-104, 2001.
81. Oligino TJ, Yao Q, Ghivizzani SC, et al: Vector systems for gene transfer to joints. Clin Orthop 379(Suppl):S17-S30, 2000.
82. Otani K, Nita I, Macaulay W, et al: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156:3558-3562, 1996.
83. Oyama M, Tatlock A, Fukuta S, et al: Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Ther 6:321-329, 1999.
84. Palmer G, Pascher A, Gouze E, et al: Development of gene-based therapies for cartilage repair. Crit Rev Eukaryot Gene Expr 12:259-273, 2002.
85. Pascher A, Palmer GD, Steinert A, et al: Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 11:133-141, 2004.
86. Pascher A, Steinert AF, Palmer GD, et al: Enhanced repair of the anterior cruciate ligament by in situ gene transfer: Evaluation in an in vitro model. Mol Ther 10:327-336, 2004.
87. Pelletier JP, Caron JP, Evans C, et al: In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 40:1012-1019, 1997.
88. Robbins PD, Evans CH: Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Ther 3:187-189, 1996.
89. Robbins PD, Evans CH, Chernajovsky Y: Gene therapy for arthritis. Gene Ther 10:902-911, 2003.
90. Roessler BJ, Allen ED, Wilson JM, et al: Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 92: 1085-1092, 1993.
91. Samuel RE, Lee CR, Ghivizzani SC, et al: Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices. Hum Gene Ther 13:791-802, 2002.
92. Saxer RA, Bent SJ, Brower-Toland BD, et al: Gene mediated insulin-like growth factor-I delivery to the synovium. J Orthop Res 19:759-767, 2001.
93. Shuler FD, Georgescu HI, Niyibizi C, et al: Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 18:585-592, 2000.
94. Sinsheimer RL: The prospect for designed genetic change. Am Sci 57:134-142, 1969.
95. Smith P, Shuler FD, Georgescu HI, et al: Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 43:1156-1164, 2000.
96. Smith-Arica JR, Bartlett JS: Gene therapy: Recombinant adeno-associated virus vectors. Curr Cardiol Rep 3:43-49, 2001.
97. Steadman JR, Rodkey WG, Rodrigo JJ: Microfracture: Surgical technique and rehabilitation to treat chondral defects. Clin Orthop 391(Suppl):S362-S369, 2001.
98. Tatum EL: Molecular biology, nucleic acids, and the future of medicine. Perspect Biol Med 10:19-32, 1966.
99. Ulrich-Vinther M, Carmody EE, Goater JJ, et al: Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg 84A:1405-1412, 2002.
100. Wallach CJ, Gilbertson LG, Kang JD: Gene therapy applications for intervertebral disc degeneration. Spine 28(15 Suppl):S93-S98, 2003.
101. Wallach CJ, Sobajima S, Watanabe Y, et al: Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 28:2331-2337, 2003.
102. Whalen JD, Lechman EL, Carlos CA, et al: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625-3632, 1999.
103. Whalen JD, Thomson AW, Lu L, et al: Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: Evidence for involvement of genetically modified dendritic cells and macrophages. Mol Ther 4:543-550, 2001.
104. Yang S, Wu B, Mayton L, et al: IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res 51:342-350, 2002.
105. Yang SY, Mayton L, Wu B, et al: Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum 46:2514-2523, 2002.
106. Yang SY, Wu B, Mayton L, et al: Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 11:483-491, 2004.
107. Yao Q, Wang S, Gambotto A, et al: Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther 10:1055-1060, 2003.
108. Yao Q, Wang S, Glorioso JC, et al: Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol Ther 3:901-910, 2001.